Handling Multiple Rounds of Regulatory Feedback
Handling Multiple Rounds of Regulatory Feedback Strategic Approaches to Managing Multiple Rounds of Regulatory Feedback Introduction: The Reality of Iterative Regulatory Review Drug development and approval processes are rarely linear. After an initial submission—be it an IND, NDA, BLA, or CTA—sponsors often receive a first round of questions from regulators. However, this may not be…
Read More “Handling Multiple Rounds of Regulatory Feedback” »